Background: Betamethasone treatment is widely used and recommended worldwide. Although, there are no enough studies to look for the risk or potential alterations due to accumulation of this drug before fertilization. In addition, previous studies payed attention to intramuscular injection during pregnancy neglecting the long-term impact of the use of topical solutions. So, the aim of the present study was to determine this side effect. Methods: We used two doses of betamethasone: 0.02 and 0.2 mg/Kg b.w. were and at the end of the experimental period (after 3 weeks of delivery), six new-born rabbits of both sexes (1 new born rabbit per mother) were dissected under light anesthesia and heart samples were collected. All the measurements were performed in one assay. Result: The results of this study revealed maternal exposure to betamethasone prior to fertilization, induced oxidative stress, alterations in levels of enzymes. Furthermore, these biochemical alterations were supported by histopathological and ultrastructural observations. So, this study suggested that females; desiring to be pregnant, should stop treatment of psoriasis with betamethasone before fertilization to avoid heart toxicity of their offspring.

Background: Betamethasone is a synthetic glucocorticoid used for treatment of Psoriasis. Until now, the side effect of maternal exposure to topical betamethasone, prior to fertilization, on newborn is not clear. So, the aim of the present study was to determine this side effect. Methods: We used two doses of betamethasone: 0.02 and 0.2 mg/kg b.w. At the end of the experimental period (after 3 weeks of delivery), six new-born rabbits of both sexes (1 newborn rabbit per mother) were dissected under light anesthesia and blood and cerebellum samples were collected. All the measurements were performed in one assay. Result: The results of this study revealed that betamethasone can bioaccumulate in sera of rabbits treated mothers. Maternal exposure to betamethasone, for 2 months before fertilization, induced oxidative stress, alterations in levels of studied neurotransmitters and increase in activities of acetylcholinesterase and caspase-3 enzymes. Furthermore, these biochemical alterations were supported by histopathological observations. So, this study suggested that females; desiring to be pregnant, should stop treatment of psoriasis with betamethasone before fertilization to avoid cerebellar toxicity of their offspring.

Background: Synthetic glucocorticoids, such as Betamethasone, are used for treatment of skin disease including Psoriasis. No enough evidences are present about the side effect of maternal exposure to betamethasone, before fertilization, on new-born. So, the goal of the present study was to determine these side effects on liver and kidney. Methods: In the present study, two doses of betamethasone (0.02 and 0.2 mg/kg b.w) were used. At the end of the experimental period (after 3 weeks of delivery), six new-born rabbits of both sexes (1 newborn rabbit per mother) were dissected under light anesthesia and blood, liver and kidney samples were collected. All the measurements were performed in one assay. Result: Maternal exposure to betamethasone, for 2 months before fertilization, induced toxicity in new-born rabbits and decrease the relative organ weight of liver and kidney in new-born rabbits. The biochemical changes involved induction of oxidative, alterations in hepatic and renal parameters. Moreover, structural changes in liver and kidney new-born rabbits were observed. So, this study suggested that females must take care in using treatment with betamethasone before fertilization to avoid toxicity of their offspring.